SERAGEN INC 3
3 · SERAGEN INC · Filed May 21, 1998
Insider Transaction Report
Form 3
No transactions or holdings reported in this filing.
Footnotes (1)
- [1]Ligand has acquired voting power with respect to certain matters of shares of common stock and preferred stock of Seragen, Inc. representing, on an as-converted basis, 118,654,461 shares of common stock of Seragen, Inc. through irrevocable proxies granted to Ligand by certain directors, officers and stockholders of Seragen, Inc. Ligand does not have any pecuniary interest in the shares. ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space provided is insufficient, See Instruction 6 for procedure. Ligand Pharmaceuticals Incorporated By: /s/ WILLIAM L. RESPESS May 21, 1998 ----------------------------------- ------------ William L. Respess, Vice President, Date General Counsel, Government Affairs (Print or Type Responses) Page 2 SEC 2270 (7-96)